JKT:CARE

PT Metro Healthcare Indonesia Tbk · JKT · Healthcare · IDR · FY for 2025

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aIDR

Market data

  • 2493.3xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • computed
    • Computed from the filing for 2025
  • 1.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -37.5%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.28Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    IDR
    • computed

Five bars, one line

lens 7 of 9
1.94x
-0.16x
0.68x
1.64x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales1.94x

    Its own average over 9 years, 226.84B.

  • Profit-0.16x

    Its own average over 10 years, -31.22B.

  • Free cash flow0.68x

    Its own average over 10 years, -241.60B.

  • Debt1.64x

    Its own average over 10 years, 508.78B.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at -0.16 times.

Sales is 1.94 times its own 9-year average; Profit is -0.16 times its own 10-year average; Free cash flow is 0.68 times its own 10-year average; Debt is 1.64 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 9-year average1.94
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    IDR
  • Profit against its own 10-year average-0.16
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    IDR
  • Free cash flow against its own 10-year average0.68
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    IDR
  • Debt against its own 10-year average1.64
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    IDR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    IDR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.